Compare PLAY & MASS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PLAY | MASS |
|---|---|---|
| Founded | 1982 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Restaurants | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 387.3M | 326.0M |
| IPO Year | 2011 | 2020 |
| Metric | PLAY | MASS |
|---|---|---|
| Price | $9.90 | $7.16 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 6 | 1 |
| Target Price | ★ $23.83 | $12.00 |
| AVG Volume (30 Days) | ★ 1.5M | 263.9K |
| Earning Date | 06-09-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 125.47 |
| EPS | ★ 0.16 | N/A |
| Revenue | N/A | ★ $56,197,000.00 |
| Revenue This Year | $5.57 | $19.44 |
| Revenue Next Year | $5.00 | $18.63 |
| P/E Ratio | $60.94 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $9.40 | $5.03 |
| 52 Week High | $33.30 | $9.34 |
| Indicator | PLAY | MASS |
|---|---|---|
| Relative Strength Index (RSI) | 42.51 | 37.11 |
| Support Level | $9.50 | $5.86 |
| Resistance Level | $10.85 | $7.45 |
| Average True Range (ATR) | 0.68 | 0.44 |
| MACD | -0.02 | -0.12 |
| Stochastic Oscillator | 33.10 | 14.04 |
Dave & Buster's Entertainment Inc is an owner and operator of entertainment and dining venues in North America that offer experiences for both adults and families under the Dave & Buster's and Main Event brands. The company combines various forms of entertainment, including games, bowling, and watching live sports and other televised events, with a full menu of entrees and appetizers and a selection of alcoholic and non alcoholic beverages, all in one location. Its concept focuses on providing customers the opportunity to Eat, Drink, Play, and Watch, appealing to a balanced mix of adults, families, and teenagers. The company also operates internationally in the early stage as a franchisor of the Dave & Buster's brand.
908 Devices Inc develops a suite of purpose-built handheld devices for point-of-need chemical analysis. Leveraging mass spectrometry, optical spectroscopy, analytics and machine learning technologies, the company makes devices that are smaller and more accessible than conventional laboratory instruments. Its devices, including MX908, ThreatID, XplorIR and VipIR, are used to analyze unknown materials and provide actionable answers in health, safety and defense technology applications, addressing the fentanyl and illicit drug crisis, toxic carcinogen exposure and security threats. The company reimagines mass spectrometry technology by developing smaller, lower-cost and simpler-to-operate devices compared to conventional instruments, and generates maximum revenue from the United States.